New York, New York, United States The leading representative office of defined VC is situated in the New York. The venture was found in North America in United States.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the NGN Capital, startups are often financed by 3i Group, Forbion Capital Partners, Neomed Management. The meaningful sponsors for the fund in investment in the same round are 3i Group, MedVenture Associates, Forbion Capital Partners. In the next rounds fund is usually obtained by Forbion Capital Partners, Arcus Ventures, 3i Group.
Besides them, we counted 6 critical employees of this fund in our database.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight OptiScan Biomedical, Aerovance, Artisan Pharma. Among the most successful fund investment fields, there are Pharmaceutical, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
The important activity for fund was in 2010. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 22 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this NGN Capital works on 1 percentage points more the average amount of lead investments. The fund is generally included in 2-6 deals every year. The higher amount of exits for fund were in 2016.
Related Funds
Funds with similar focus
| Fund Name | Location |
| FINODEX Accelerator | Navarre, Pamplona, Spain |
| Furukawa Ringyo | Japan, Tokyo |
| Hyper Ventures | England, London, United Kingdom |
| Icco AG | - |
| James Madison Innovations | - |
| Rui Zhong Dian Zi | Anhui, Bozhou, China |
| Shad Run Investments | California, San Francisco, United States |
| Starta Ventures | New York, New York, United States |
| WeStaking | - |
| WQ Investments | California, Los Altos, United States |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Exosome Diagnostics | $30M | 24 Jul 2017 | New York, New York, United States | ||
Exosome Diagnostics | $16M | 07 Jan 2016 | New York, New York, United States | ||
Exosome Diagnostics | $17M | 02 Sep 2015 | New York, New York, United States | ||
Exosome Diagnostics | $27M | 11 Mar 2014 | New York, New York, United States | ||
PIN Pharma | $6M | 01 Jan 2014 | New York, New York, United States | ||
Endosense | $40M | 27 Nov 2013 | Geneva, Geneva, Switzerland | ||
Endosense | $40M | 27 Nov 2012 | Geneva, Switzerland | ||
Artisan Pharma | $3M | 20 Jul 2010 | Massachusetts, United States | ||
Exosome Diagnostics | $20M | 11 May 2010 | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Exosome Diagnostics | $30M | 24 Jul 2017 | New York, New York, United States | ||
Exosome Diagnostics | $16M | 07 Jan 2016 | New York, New York, United States | ||
Exosome Diagnostics | $17M | 02 Sep 2015 | New York, New York, United States | ||
Exosome Diagnostics | $27M | 11 Mar 2014 | New York, New York, United States | ||
PIN Pharma | $6M | 01 Jan 2014 | New York, New York, United States | ||
Endosense | $40M | 27 Nov 2013 | Geneva, Geneva, Switzerland | ||
Endosense | $40M | 27 Nov 2012 | Geneva, Switzerland | ||
Artisan Pharma | $3M | 20 Jul 2010 | Massachusetts, United States | ||
Exosome Diagnostics | $20M | 11 May 2010 | New York, New York, United States |
